Back to Search
Start Over
Oxidation of cofilin mediates T cell hyporesponsiveness under oxidative stress conditions.
- Source :
-
Immunity [Immunity] 2008 Sep 19; Vol. 29 (3), pp. 404-13. Date of Electronic Publication: 2008 Sep 04. - Publication Year :
- 2008
-
Abstract
- Oxidative stress leads to impaired T cell activation. A central integrator of T cell activation is the actin-remodelling protein cofilin. Cofilin is activated through dephosphorylation at Ser3. Activated cofilin enables actin dynamics through severing and depolymerization of F-actin. Binding of cofilin to actin is required for formation of the immune synapse and T cell activation. Here, we showed that oxidatively stressed human T cells were impaired in chemotaxis- and costimulation-induced F-actin modulation. Although cofilin was dephosphorylated, steady-state F-actin levels increased under oxidative stress conditions. Mass spectrometry revealed that cofilin itself was a target for oxidation. Cofilin oxidation induced formation of an intramolecular disulfide bridge and loss of its Ser3 phosphorylation. Importantly, dephosphorylated oxidized cofilin, although still able to bind to F-actin, did not mediate F-actin depolymerization. Impairing actin dynamics through oxidation of cofilin provides a molecular explanation for the T cell hyporesponsiveness caused by oxidative stress.
- Subjects :
- Actin Depolymerizing Factors chemistry
CD28 Antigens immunology
CD3 Complex immunology
Chemotaxis, Leukocyte
Humans
Hydrogen Peroxide metabolism
Lim Kinases metabolism
Neutrophil Activation
Neutrophils metabolism
Oxidation-Reduction
Phosphorylation
T-Lymphocytes metabolism
Actin Depolymerizing Factors metabolism
Actins metabolism
Lymphocyte Activation
Neutrophils immunology
Oxidative Stress
T-Lymphocytes immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1097-4180
- Volume :
- 29
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Immunity
- Publication Type :
- Academic Journal
- Accession number :
- 18771940
- Full Text :
- https://doi.org/10.1016/j.immuni.2008.06.016